INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $931,000 | -61.6% | 700,000 | +126.5% | 0.00% | -60.0% |
| Q4 2015 | $2,426,000 | -13.6% | 309,095 | -7.0% | 0.01% | -16.7% |
| Q3 2015 | $2,807,000 | -29.5% | 332,200 | -8.7% | 0.01% | -20.0% |
| Q2 2015 | $3,983,000 | +188.4% | 363,751 | +268.4% | 0.02% | +200.0% |
| Q1 2015 | $1,381,000 | -45.0% | 98,751 | -33.6% | 0.01% | -44.4% |
| Q4 2014 | $2,512,000 | -38.7% | 148,751 | -51.3% | 0.01% | -40.0% |
| Q3 2014 | $4,099,000 | +4.0% | 305,451 | -1.3% | 0.02% | +15.4% |
| Q2 2014 | $3,942,000 | +22.5% | 309,451 | +14.3% | 0.01% | +8.3% |
| Q1 2014 | $3,219,000 | -1.0% | 270,750 | +15.0% | 0.01% | 0.0% |
| Q4 2013 | $3,250,000 | -34.9% | 235,350 | -17.7% | 0.01% | -36.8% |
| Q3 2013 | $4,991,000 | +15.5% | 286,000 | +7.5% | 0.02% | +11.8% |
| Q2 2013 | $4,323,000 | – | 266,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |